Randomized trial of FOLFOX alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient DNA mismatch repair or microsatellite instability (ATOMIC, Alliance A021502) - Sinicrope, FA; Ou, FS; Shi, Q (J Clin Oncol, 2017)
et al.